Literature DB >> 23408534

Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.

Jacqueline G O'Leary, Gregory J McKenna, Göran B Klintmalm, Gary L Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23408534     DOI： 10.1002/lt.23623

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  7 in total

Review 1.  Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.

Authors:  Sarah Tischer; Robert J Fontana
Journal:  J Hepatol       Date:  2013-11-23       Impact factor: 25.083

2.  A Generic Model for Quantitative Prediction of Interactions Mediated by Efflux Transporters and Cytochromes: Application to P-Glycoprotein and Cytochrome 3A4.

Authors:  Michel Tod; S Goutelle; N Bleyzac; L Bourguignon
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

Review 3.  Drug interactions and protease inhibitors used in the treatment of hepatitis C: how to manage?

Authors:  Sarah Talavera Pons; Geraldine Lamblin; Anne Boyer; Valérie Sautou; Armand Abergel
Journal:  Eur J Clin Pharmacol       Date:  2014-05-10       Impact factor: 2.953

4.  Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.

Authors:  Elizabeth C Verna; Varun Saxena; James R Burton; Jacqueline G O'Leary; Jennifer L Dodge; Richard T Stravitz; Josh Levitsky; James F Trotter; Gregory T Everson; Robert S Brown; Norah A Terrault
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

5.  A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.

Authors:  James R Burton; Jacqueline G O'Leary; Elizabeth C Verna; Varun Saxena; Jennifer L Dodge; Richard T Stravitz; Joshua Levitsky; James F Trotter; Gregory T Everson; Robert S Brown; Norah A Terrault
Journal:  J Hepatol       Date:  2014-05-05       Impact factor: 25.083

Review 6.  Drug-drug interactions during antiviral therapy for chronic hepatitis C.

Authors:  Jennifer J Kiser; James R Burton; Gregory T Everson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

Review 7.  Management of post transplant hepatitis C in the direct antiviral agents era.

Authors:  Audrey Coilly; Bruno Roche; Jean-Charles Duclos-Vallée; Didier Samuel
Journal:  Hepatol Int       Date:  2015-03-28       Impact factor: 6.047
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.